Dr. Kost is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
903 W Martin
San Antonio, TX 78207Phone+1 210-358-3582Fax+1 210-358-3252
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Gynecologic Oncology, 1994 - 1996
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1989
Certifications & Licensure
- TX State Medical License 2002 - 2026
- CA State Medical License 1991 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer.Lois Randolph, Jaitri Joshi, Alondra Lee Rodriguez Sanchez, Uday P Pratap, Rahul Gopalam
Cancers. 2024-10-28 - KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.Yihong Chen, Jessica D Johnson, Sridharan Jayamohan, Yi He, Prabhakar P Venkata
Molecular Carcinogenesis. 2024-10-01 - 4 citationsPELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.Xue Yang, Zexuan Liu, Weiwei Tang, Uday P Pratap, Alexia B Collier
Molecular Oncology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: